Annals of Clinical and Translational Neurology · 2024 · 11 citations · 14 references
Life SciencesImmunologyNeurologyAutoimmunityImmunopathologyNeuroimmunologyAutoimmune DiseasesAutoimmune Neurological DisordersOptic NeuritisAquaporin-4 Antibody DiseaseDisability Status AnalysisDisability Status DeterminationMatched StudiesMortality Data CollectionStandardized Mortality RatesStandardized Mortality Statistics
Neuromyelitis optica spectrum disorder is an autoimmune disease, causing severe disability due to relapses, but recent mortality data are limited. Among 396 patients seropositive for anti-aquaporin-4 antibody from 2014 to 2020 in the United Kingdom, 39 deaths occurred: 19 (48.7%) were unrelated to disease; 14 (35.9%) were severe disability- or relapse-related; and 4 (10.3%) were attributed to malignancy/infection. Mean annual mortality was 1.92% versus 0.63% in the matched population. The standardized mortality ratio was 3.04 (95% confidence interval 1.67-5.30) with 1.29% excess mortality per year in patients. Median Expanded Disability Status Scale before death was 7.0. Results highlight the importance of preventing relapses that drive disability.
14
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
Patrick Waters, Andrew McKeon, Maria Isabel Leite et al. · Neurology · 2012 · 526 citations · Full text
Life Sciences, Immunology, Neurology +14
Racial differences in neuromyelitis optica spectrum disorder
Su‐Hyun Kim, Maureen A. Mealy, Michael Levy et al. · Neurology · 2018 · 176 citations · Full text